Cat. No. | Product name | CAS No. |
DCC5285 |
Ubp646
Novel pan potentiator of GluN1/GluN2 receptors |
1333213-35-6 |
DCC5286 |
Ubp684
Novel NMDAR positive allosteric modulator (PAM), robustly potentiating responses at all GluN1/GluN2 subtypes and at neuronal NMDARs |
1357838-47-1 |
DCC5287 |
Ubtr008295a
Novel Antagonist of the USP5 Zinc Finger Ubiquitin-Binding Domain (USP5 ZnF-UBD) |
6947-81-5 |
DCC5288 |
Ucb-11056
Modulator of cyclic AMP generation, amplifing induced cyclic AMP formation in rat brain tissue; Nootropic |
127390-77-6 |
DCC5289 |
ucb30889
Potent ligand of synaptic vesicle protein 2A (SV2A) |
650608-19-8 |
DCC5290 |
Ucb-6786
Novel inhibitor of TNF signalling by stabilising an asymmetric form of the trimer, displaying a concentration-dependent response curve and selectivity over the TNFR1 extracellular domain and control proteins |
537018-21-6 |
DCC5291 |
Ucb-6876
Novel inhibitor of TNF signalling by stabilising an asymmetric form of the trimer, displaying a concentration-dependent response curve and selectivity over the TNFR1 extracellular domain and control proteins |
637324-45-9 |
DCC5292 |
Ucb-fcrn-303
Novel allosteric modulator of neonatal Fc receptor (FcRn), binding to the extracellular domain of FcRn |
|
DCC5293 |
uc-ddc-918013
Selective competitive inhibitor of ATX-mediated hydrolysis of the lysophospholipase substrate FS-3 |
313685-55-1 |
DCC5294 |
uc-ddc-931126
Selective competitive inhibitor of ATX-mediated hydrolysis of the lysophospholipase substrate FS-3 |
736966-32-8 |
DCC5295 |
uc-ddc-966791
Competitive dual inhibitor of the hydrolysis FS-3 and the phosphodiesterase substrate p-nitrophenyl thymidine 5'-monophosphate |
485317-08-6 |
DCC5297 |
Uck2-in-135546734
Novel non-competitive UCK2 inhibitor, suppressing nucleoside salvage in cells both in the presence and absence of DHODH inhibitors |
|
DCC5298 |
Uck2-in-135546812
Novel non-competitive UCK2 inhibitor, suppressing nucleoside salvage in cells both in the presence and absence of DHODH inhibitors |
|
DCC5299 |
Uck2-in-20874830
Novel non-competitive UCK2 inhibitor, suppressing nucleoside salvage in cells both in the presence and absence of DHODH inhibitors |
866842-71-9 |
DCC5300 |
ucl-1972
Histamine H3 Receptor Antagonist in Treatments of Cognition Disorders |
220728-17-6 |
DCC5301 |
Ucl-2190 Hydrogen Maleate
The first potent nonimidazole H3 receptor antagonist (pKi=8.40) |
|
DCC5302 |
Ucm-05194
Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), Showing Efficacy in Neuropathic Pain Amelioration |
2400858-74-2 |
DCC5303 |
Ucm-1336
Novel potent isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor, improving survival in Ras-driven acute myeloid leukemia |
1621535-90-7 |
DCC5304 |
Ucm710
Dual inhibitor of fatty acid amide hydrolase (FAAH) and α/β hydrolase domain 6 (ABHD6) |
213738-77-3 |
DCC5305 |
Ucn-02
Stereoisomer of UCN-01, inhibiting protein kinase C with a slightly reduced potency than UCN-01 |
121569-61-7 |
DCC5306 |
Ucp1172
Novel dual inhibitor of dihydrofolate reductase (DHFR) and its functional analog, Rv2671 |
|
DCC5307 |
Ucph-102f
Fluorescent excitatory amino acid transporter subtype 1 (EAAT1) selective inhibitor |